Citizens Holding Company reported Q1 results this week, posting a revenue increase to $14.4 million from $13.0 million a year ago — and the stock climbed quietly, but the more interesting story is happening in the borrow market.
The clearest signal this week is the cost to borrow. Borrowing costs have tripled since mid-March, rising from around 1.6% to 5.4% annualised by April 28 — the highest level in the data window going back to late 2025. That's a meaningful acceleration: costs are up 25% just in the past week, and up more than 400% over the past month. For a $53 million market-cap OTC community bank, that kind of shift in the lending market is worth watching, even if absolute short positioning remains thin.
Short interest itself is very low. Short shares represent just 0.18% of the free float — firmly in the range where it has no meaningful narrative weight. Week-on-week, estimated short shares edged up around 9%, but that moves the absolute figure only marginally, from roughly 9,600 to 10,000 shares. With availability running at 566% of current short interest, the lending pool is far from tight — there are more than five shares available to borrow for every one already lent out. That rules out any squeeze dynamic. The borrow cost spike, then, reflects something more nuanced: rising demand at the margins, or a small pool of shares where even modest new activity moves the rate.
The short score sits at 39.7, up from 33 as recently as April 22. That's a notable six-point jump in under a week. The utilization rank comes in at the 7th percentile — meaning CIZN sits near the bottom of the universe on how much of its lending pool is actually in use, consistent with the wide availability figure. The sector score ranks at the 50th percentile, neutral relative to peers in regional banking.
On the earnings front, Q1 net income came in at $1.89 million, up slightly from $1.85 million a year earlier. EPS held flat at $0.33. Net interest income grew to $11.3 million from $10.1 million — a solid 12% increase year-on-year, suggesting margin recovery is continuing. The stock has responded in kind: up 2.8% on the week, up 5.7% over the past month, and trading around $9.51. The Q4 2025 print showed stronger momentum — EPS was $0.37 versus $0.23 a year prior — so Q1 represents a slight deceleration in earnings growth even as revenue accelerates.
Insider data is stale, with the most recent disclosed trades dating to February 2024. Those trades showed the Chairman and subsidiary CEO building positions around the $7.73–$7.89 range — well below today's price — but the data is too old to carry current weight. Dividend history similarly tails off in mid-2022, suggesting no active dividend programme.
What to watch next: whether the cost-to-borrow elevation persists or normalises now that the earnings catalyst has passed, and whether the short score continues its recent upward drift toward levels that might indicate more organised short-side interest in this micro-cap bank.
See the live data behind this article on ORTEX.
Open CIZN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
